219 related articles for article (PubMed ID: 23359353)
1. Predictors of poor outcome in patients w ith autoimmune hepatitis: a population-based study.
Ngu JH; Gearry RB; Frampton CM; Stedman CA
Hepatology; 2013 Jun; 57(6):2399-406. PubMed ID: 23359353
[TBL] [Abstract][Full Text] [Related]
2. Favorable outcomes of autoimmune hepatitis in a community clinic setting.
Seo S; Toutounjian R; Conrad A; Blatt L; Tong MJ
J Gastroenterol Hepatol; 2008 Sep; 23(9):1410-4. PubMed ID: 18373564
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center.
Hoeroldt B; McFarlane E; Dube A; Basumani P; Karajeh M; Campbell MJ; Gleeson D
Gastroenterology; 2011 Jun; 140(7):1980-9. PubMed ID: 21396370
[TBL] [Abstract][Full Text] [Related]
4. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.
Verma S; Gunuwan B; Mendler M; Govindrajan S; Redeker A
Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune Hepatitis: Predictors of Native Liver Survival in Children and Adolescents.
Porta G; de Carvalho E; Santos JL; Gama J; Bezerra JA;
J Pediatr; 2021 Feb; 229():95-101.e3. PubMed ID: 33500120
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response.
Werner M; Wallerstedt S; Lindgren S; Almer S; Björnsson E; Bergquist A; Prytz H; Sandberg-Gertzén H; Hultcrantz R; Sangfelt P; Weiland O; Ohlsson B; Danielsson A
Scand J Gastroenterol; 2010 Apr; 45(4):457-67. PubMed ID: 20082594
[TBL] [Abstract][Full Text] [Related]
7. The natural history of autoimmune hepatitis presenting with jaundice.
Panayi V; Froud OJ; Vine L; Laurent P; Woolson KL; Hunter JG; Madden RG; Miller C; Palmer J; Harris N; Mathew J; Stableforth B; Murray IA; Dalton HR
Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):640-5. PubMed ID: 24694760
[TBL] [Abstract][Full Text] [Related]
8. Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis.
Miyake Y; Iwasaki Y; Terada R; Takagi S; Okamaoto R; Ikeda H; Sakai N; Makino Y; Kobashi H; Takaguchi K; Sakaguchi K; Shiratori Y
J Hepatol; 2005 Dec; 43(6):951-7. PubMed ID: 16143423
[TBL] [Abstract][Full Text] [Related]
9. Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes.
Aljumah AA; Al-Ashgar H; Fallatah H; Albenmousa A
Ann Hepatol; 2019; 18(3):439-444. PubMed ID: 31040094
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.
Feld JJ; Dinh H; Arenovich T; Marcus VA; Wanless IR; Heathcote EJ
Hepatology; 2005 Jul; 42(1):53-62. PubMed ID: 15954109
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors of poor response to therapy in Autoimmune Hepatitis.
Muratori P; Lalanne C; Bianchi G; Lenzi M; Muratori L
Dig Liver Dis; 2016 Sep; 48(9):1078-81. PubMed ID: 27378707
[TBL] [Abstract][Full Text] [Related]
12. Incidence and Characteristics of Autoimmune Hepatitis.
Jiménez-Rivera C; Ling SC; Ahmed N; Yap J; Aglipay M; Barrowman N; Graitson S; Critch J; Rashid M; Ng VL; Roberts EA; Brill H; Dowhaniuk JK; Bruce G; Bax K; Deneau M; Guttman OR; Schreiber RA; Martin S; Alvarez F
Pediatrics; 2015 Nov; 136(5):e1237-48. PubMed ID: 26482664
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a prognostic score for long-term transplant-free survival in autoimmune hepatitis type 1.
Biewenga M; Verhelst XPDMJ; Baven-Pronk MAMC; Putter H; van den Berg AP; van Nieuwkerk KCMJ; van Buuren HR; Bouma G; de Boer YS; Simoen C; Colle I; Schouten J; Sermon F; van Steenkiste C; van Vlierberghe H; van der Meer AJ; Nevens F; van Hoek B;
United European Gastroenterol J; 2021 Jul; 9(6):662-671. PubMed ID: 34165262
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma and survival in patients with autoimmune hepatitis (Japanese National Hospital Organization-autoimmune hepatitis prospective study).
Migita K; Watanabe Y; Jiuchi Y; Nakamura Y; Saito A; Yagura M; Ohta H; Shimada M; Mita E; Hijioka T; Yamashita H; Takezaki E; Muro T; Sakai H; Nakamuta M; Abiru S; Komori A; Ito M; Yatsuhashi H; Nakamura M; Ishibashi H;
Liver Int; 2012 May; 32(5):837-44. PubMed ID: 22221966
[TBL] [Abstract][Full Text] [Related]
15. Mortality and the risk of malignancy in autoimmune liver diseases: a population-based study in Canterbury, New Zealand.
Ngu JH; Gearry RB; Frampton CM; Stedman CA
Hepatology; 2012 Feb; 55(2):522-9. PubMed ID: 21994151
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis.
Dhaliwal HK; Hoeroldt BS; Dube AK; McFarlane E; Underwood JC; Karajeh MA; Gleeson D
Am J Gastroenterol; 2015 Jul; 110(7):993-9. PubMed ID: 26010310
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis.
Danielsson Borssén Å; Marschall HU; Bergquist A; Rorsman F; Weiland O; Kechagias S; Nyhlin N; Verbaan H; Nilsson E; Werner M
Scand J Gastroenterol; 2017 Sep; 52(9):1022-1028. PubMed ID: 28562110
[TBL] [Abstract][Full Text] [Related]
18. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes.
Yokokawa J; Saito H; Kanno Y; Honma F; Monoe K; Sakamoto N; Abe K; Takahashi A; Yokokawa H; Ohira H
J Gastroenterol Hepatol; 2010 Feb; 25(2):376-82. PubMed ID: 19817953
[TBL] [Abstract][Full Text] [Related]
19. Role of age in presentation, response to therapy and outcome of autoimmune hepatitis.
Baven-Pronk MAMC; Biewenga M; van Silfhout JJ; van den Berg AP; van Buuren HR; Verwer BJ; van Nieuwkerk CMJ; Bouma G; van Hoek B
Clin Transl Gastroenterol; 2018 Jul; 9(6):165. PubMed ID: 29961755
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP).
Fattovich G; Giustina G; Realdi G; Corrocher R; Schalm SW
Hepatology; 1997 Nov; 26(5):1338-42. PubMed ID: 9362381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
